Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-05-12
DOI
10.1038/srep25626
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nerve-Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression
- (2015) P. Jobling et al. CANCER RESEARCH
- The re-emergence of natural products for drug discovery in the genomics era
- (2015) Alan L. Harvey et al. NATURE REVIEWS DRUG DISCOVERY
- Neural Regulation of Hematopoiesis, Inflammation, and Cancer
- (2015) Maher Hanoun et al. NEURON
- First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors
- (2014) D. S. Hong et al. INVESTIGATIONAL NEW DRUGS
- PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway
- (2014) Yong Pan et al. INVESTIGATIONAL NEW DRUGS
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- BDNF Mediates Neuroprotection against Oxygen-Glucose Deprivation by the Cardiac Glycoside Oleandrin
- (2014) Michael J. Van Kanegan et al. JOURNAL OF NEUROSCIENCE
- Ursolic acid reduces oxidative stress to alleviate early brain injury following experimental subarachnoid hemorrhage
- (2014) Tingting Zhang et al. NEUROSCIENCE LETTERS
- Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition
- (2014) A. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
- (2014) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Targeting Nrf2-Mediated Gene Transcription by Triterpenoids and Their Derivatives
- (2013) Agnieszka Loboda et al. Biomolecules & Therapeutics
- BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety
- (2013) Robert J. Fox et al. CURRENT MEDICAL RESEARCH AND OPINION
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis
- (2013) Martin Stangel et al. Expert Review of Clinical Pharmacology
- Bardoxolone Brings Nrf2-Based Therapies to Light
- (2012) Donna D. Zhang ANTIOXIDANTS & REDOX SIGNALING
- Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice
- (2012) Litao Li et al. BRAIN RESEARCH
- Pathophysiologic Cascades in Ischemic Stroke
- (2012) Changhong Xing et al. International Journal of Stroke
- The immunology of neurodegeneration
- (2012) Eva Czirr et al. JOURNAL OF CLINICAL INVESTIGATION
- Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B
- (2012) Tania Tahtouh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
- (2012) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models
- (2012) P. E. Cramer et al. SCIENCE
- Pharmacological Induction of Heme Oxygenase-1 by a Triterpenoid Protects Neurons Against Ischemic Injury
- (2012) Feng Zhang et al. STROKE
- In vitro and in vivo neuroprotective activity of the cardiac glycoside oleandrin from Nerium oleander in brain slice-based stroke models
- (2011) Denise E. Dunn et al. JOURNAL OF NEUROCHEMISTRY
- Understanding the link between cancer and neurodegeneration
- (2011) Jane A. Driver Journal of Geriatric Oncology
- The Nrf2-ARE Pathway
- (2010) Jeffrey A. Johnson et al. Annals of the New York Academy of Sciences
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- Identification and Evaluation of Small Molecule Pan-Caspase Inhibitors in Huntington's Disease Models
- (2010) Melissa J. Leyva et al. CHEMISTRY & BIOLOGY
- Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins
- (2010) Benjamin G Hoffstrom et al. Nature Chemical Biology
- Alzheimer's disease: strategies for disease modification
- (2010) Martin Citron NATURE REVIEWS DRUG DISCOVERY
- Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease
- (2010) Steven P. Braithwaite et al. NEUROBIOLOGY OF DISEASE
- Cancer and Neurodegeneration: Between the Devil and the Deep Blue Sea
- (2010) Hélène Plun-Favreau et al. PLoS Genetics
- Does neuroinflammation fan the flame in neurodegenerative diseases?
- (2009) Tamy C Frank-Cannon et al. Molecular Neurodegeneration
- Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription
- (2009) Lichuan Yang et al. PLoS One
- Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease
- (2008) Willeke MC van Roon-Mom et al. BMC MOLECULAR BIOLOGY
- Nrf2-induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease?
- (2008) Helga E. de Vries et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cardiac Glycosides as Novel Cancer Therapeutic Agents
- (2008) R. A. Newman et al. MOLECULAR INTERVENTIONS
- The development of stroke therapeutics: Promising mechanisms and translational challenges
- (2008) Margaret M. Zaleska et al. NEUROPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started